• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® TRI-LOBE BALLOON CATHETER; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® TRI-LOBE BALLOON CATHETER; CATHETER, PERCUTANEOUS Back to Search Results
Catalog Number BCL2645
Device Problem Leak/Splash (1354)
Patient Problems Hemorrhage/Bleeding (1888); Rupture (2208)
Event Date 07/05/2016
Event Type  Injury  
Manufacturer Narrative
Medications - acetaminophen, allopurinol, amlodipine, atenolo, centrum, claritin, clonazepam, levothyroxine sodium, losartan potassium, lutein, metformin, pravastatin, vitamin d, and warfarin.(b)(4).
 
Event Description
On (b)(6) 2016, the patient underwent treatment of a thoracic aortic aneurysm with conformable gore® tag® thoracic endoprostheses.It was reported following the implant of two conformable gore® tag® thoracic endoprostheses, final imaging identified a possible distal type i or type ii endoleak.An additional conformable gore® tag® thoracic endoprostheses was implanted to extend distally to the level of the celiac to treat the endoleak.It was reported final touch up ballooning was performed.However, the endoleak reportedly was still present.It was reported after the follow-up ballooning a rupture of the aorta was identified.The patient's anatomy reportedly did not contribute to the rupture of the aortic wall.It was also reported the balloon was not inflated outside of the graft.A small amount of contrast was identified outside of the aortic wall.However, the amount of blood loss is unknown.It was reported the physician implanted another conformable gore® tag® thoracic endoprosthesis covering the celiac artery to successfully treat the rupture.Final imaging identified the initial endoleak to be a type ii endoleak.The patient tolerated the procedure.
 
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.
 
Event Description
An additional conformable gore tag thoracic endoprostheses (tgu282810/14648565) was implanted to extend distally to the level of the celiac to treat the endoleak.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® TRI-LOBE BALLOON CATHETER
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
marcos ayala
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key5848840
MDR Text Key51224564
Report Number2017233-2016-00681
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K081799
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 09/27/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/04/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/07/2018
Device Catalogue NumberBCL2645
Device Lot Number13751259
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/08/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age86 YR
Patient Weight56
-
-